126 related articles for article (PubMed ID: 35151213)
1. Esculentoside A alleviates cognitive deficits and amyloid pathology through peroxisome proliferator-activated receptor γ-dependent mechanism in an Alzheimer's disease model.
He Z; Li X; Wang Z; Tu S; Feng J; Du X; Ni J; Li N; Liu Q
Phytomedicine; 2022 Apr; 98():153956. PubMed ID: 35151213
[TBL] [Abstract][Full Text] [Related]
2. The protective effects of Esculentoside A through AMPK in the triple transgenic mouse model of Alzheimer's disease.
He Z; Zhang H; Li X; Tu S; Wang Z; Han S; Du X; Shen L; Li N; Liu Q
Phytomedicine; 2023 Jan; 109():154555. PubMed ID: 36610160
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of luteolin against amyloid beta-induced oxidative stress and mitochondrial impairments through peroxisome proliferator-activated receptor γ-dependent mechanism in Alzheimer's disease.
He Z; Li X; Wang Z; Cao Y; Han S; Li N; Cai J; Cheng S; Liu Q
Redox Biol; 2023 Oct; 66():102848. PubMed ID: 37597424
[TBL] [Abstract][Full Text] [Related]
4. Bis(ethylmaltolato)oxidovanadium (IV) alleviates neuronal apoptosis through regulating peroxisome proliferator-activated receptor γ in a triple transgenic animal model of Alzheimer's disease.
He Z; Song J; Li X; Li X; Zhu H; Wu C; Xiao W; Du X; Ni J; Li N; Liu Q
J Biol Inorg Chem; 2021 Aug; 26(5):551-568. PubMed ID: 34240269
[TBL] [Abstract][Full Text] [Related]
5. Bis(ethylmaltolato)oxidovanadium (IV) mitigates neuronal apoptosis resulted from amyloid-beta induced endoplasmic reticulum stress through activating peroxisome proliferator-activated receptor γ.
He Z; Wang M; Zhao Q; Li X; Liu P; Ren B; Wu C; Du X; Li N; Liu Q
J Inorg Biochem; 2020 Jul; 208():111073. PubMed ID: 32466853
[TBL] [Abstract][Full Text] [Related]
6. Esculentoside A suppresses Aβ(1-42)-induced neuroinflammation by down-regulating MAPKs pathways in vivo.
Yang H; Wang S; Yu L; Zhu X; Xu Y
Neurol Res; 2015 Oct; 37(10):859-66. PubMed ID: 26104317
[TBL] [Abstract][Full Text] [Related]
7. Comparative proteomic analysis of cerebral cortex revealed neuroprotective mechanism of esculentoside A on Alzheimer's disease.
He Z; Zhang H; Li X; Shen L; Li N; Cheng S; Liu Q
Eur J Pharmacol; 2024 Feb; 964():176226. PubMed ID: 38128868
[TBL] [Abstract][Full Text] [Related]
8. Berberine ameliorates iron levels and ferroptosis in the brain of 3 × Tg-AD mice.
Li X; Chen J; Feng W; Wang C; Chen M; Li Y; Chen J; Liu X; Liu Q; Tian J
Phytomedicine; 2023 Sep; 118():154962. PubMed ID: 37506403
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models.
Liu Y; Zhang Y; Liu P; Bai H; Li X; Xiao J; Yuan Q; Geng S; Yin H; Zhang H; Wang Z; Li J; Wang S; Wang Y
Eur J Pharmacol; 2019 Jan; 843():134-144. PubMed ID: 30412727
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
[TBL] [Abstract][Full Text] [Related]
11. Trans-Cinnamaldehyde Alleviates Amyloid-Beta Pathogenesis via the SIRT1-PGC1α-PPARγ Pathway in 5XFAD Transgenic Mice.
Do J; Kim N; Jeon SH; Gee MS; Ju YJ; Kim JH; Oh MS; Lee JK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599846
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone rescues human neural stem cells from amyloid-beta induced ER stress via PPARγ dependent signaling.
Lin CH; Nicol CJB; Cheng YC; Chen SJ; Yen CH; Huang RN; Chiang MC
Exp Cell Res; 2018 Sep; 370(2):312-321. PubMed ID: 29964054
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease amyloid-β pathology in the lens of the eye.
Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
15. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin Gallate Attenuates β-Amyloid Generation and Oxidative Stress Involvement of PPARγ in N2a/APP695 Cells.
Zhang ZX; Li YB; Zhao RP
Neurochem Res; 2017 Feb; 42(2):468-480. PubMed ID: 27889855
[TBL] [Abstract][Full Text] [Related]
17. CDK5 Participates in Amyloid-β Production by Regulating PPARγ Phosphorylation in Primary Rat Hippocampal Neurons.
Quan Q; Qian Y; Li X; Li M
J Alzheimers Dis; 2019; 71(2):443-460. PubMed ID: 31403945
[TBL] [Abstract][Full Text] [Related]
18. Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments.
Fu XX; Wei B; Cao HM; Duan R; Deng Y; Lian HW; Zhang YD; Jiang T
J Alzheimers Dis; 2023; 94(3):919-933. PubMed ID: 37355897
[TBL] [Abstract][Full Text] [Related]
19. Intranasal 15d-PGJ2 ameliorates brain glucose hypometabolism via PPARγ-dependent activation of PGC-1α/GLUT4 signalling in APP/PS1 transgenic mice.
Li Z; Zhang Y; Zheng Y; Liu W; Zhang X; Li W; Zhang D; Cai Q; Wang S; Meng X; Huang G
Neuropharmacology; 2021 Sep; 196():108685. PubMed ID: 34175325
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV, a Natural PPARγ Agonist, Reduces Aβ Production in Alzheimer's Disease Through Inhibition of BACE1.
Wang X; Wang Y; Hu JP; Yu S; Li BK; Cui Y; Ren L; Zhang LD
Mol Neurobiol; 2017 May; 54(4):2939-2949. PubMed ID: 27023226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
